Data as of Dec 19
| -0.25 / -10.96%|
The 5 analysts offering 12-month price forecasts for OncoGenex Pharmaceuticals Inc have a median target of 8.00, with a high estimate of 14.00 and a low estimate of 4.75. The median estimate represents a +294.09% increase from the last price of 2.03.
The current consensus among 5 polled investment analysts is to Buy stock in OncoGenex Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.